Company intelligence / Profile preview

biosyn Arzneimittel

Fellbach, Baden-Württemberg, Germany
Ownership
Private
Employees
~100
Development stage
Other
01

Overview

biosyn Arzneimittel is a family-owned pharmaceutical and biotech company based in Fellbach, Germany, specializing in trace elements, intensive care, and oncology. The company is a world leader in the production of high-purity Keyhole Limpet Hemocyanin (KLH), used both as a therapeutic for bladder cancer and as an adjuvant or carrier protein in immunotherapy and vaccine development. Their product portfolio includes Selenase, a leading selenium preparation for treating deficiency and supporting patients in intensive care and oncology. biosyn operates its own GMP-certified manufacturing facilities and maintains a global distribution network covering over 25 countries. The company is recognized for its sustainable sourcing of KLH from the California Keyhole Limpet. Through its focus on niche medical needs, biosyn has established itself as a key player in the global supply chain for specialized immunotherapies.

Therapeutic areas
OncologyEndocrinologyInfectious DiseasesMetabolic Disorders
Modalities
BiologicSmall moleculeProteinVaccine
Industry
Biotech
02

Drug pipeline

7 assets

CAREIMMUN Onco

Unknown

6 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on biosyn Arzneimittel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on biosyn Arzneimittel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call